Univ. Prof. Dr. med. Marcus Hacker
nuclear medicine and prostate cancer
nuclear medicine and prostate cancer
Overview
Country, City
Austria, Vienna
Health facility
University Hospital Vienna (AKH)
Medical unit
Department of nuclear medicine
About the doctor
Skills & Expertise
cancer
petct
prostate
prostate cancer
brain
18ffdg
nuclear medicine
coronary artery
castrationresistant prostate cancer
petmri
carcinoma
adipose tissue
lymphoma
18ffdg petct
covid19
ct
spect
thyroid
cxcr4 expression
tumor
molecular imaging
myocardial perfusion
metabolism
hepatocellular carcinoma
fibroblast activation
177lupsma
68gadotatate
68gapentixafor
68gadotatate petct
artery stenoses
cardiac resynchronization
ct angiography
dopamine d23 receptor
dynamic 68gafapi04 petct
r11cverapamil pet
hepatic disposition
imageguided therapy
biomedical imaging
metastases
177lupsma therapy
68gapentixafor petmri
salivary gland
cardiac sarcoidosis
malt lymphoma
hormone receptor
androgen receptor
thyroid carcinoma
heart failure
lymph node
actinium 225
Gallery
Impulses from #Seitenstetten: Univ.-Prof. Dr. Marcus Hacker
AIPES Symposium 2018 - Panel discussion
Marcus Hacker: Diagnostic imaging of CHD: Why is myocardial scintigraphy superior?
OGNMB Prof Marcus Hacker I Large 540p
Resume
CV (Curriculum Vitae)
Education
- 1990-1991 Research Assistant at the Institute of Biochemistry of the Chair of Physiological Chemistry
- 1998 Studied human medicine in Erlangen and Munich
- Obtaining a license for medical practice
- 2000-2007 Scientific Assistant in the Department of nuclear medicine at the Ludwig Maximilian University of Munich
- 2004 Obtaining specialization in nuclear medicine
- 2012 Extraordinary Professor at the Ludwig Maximilian University of Munich
- 2013 University Professor of the Medical University of Vienna
Experience
- 2007 Senior Physician for cardiovascular imaging and Deputy Head of PET/CT at the Department of nuclear medicine of the Ludwig Maximilian University of Munich
- 2009 Senior Consultant and Deputy Director of the Department of nuclear medicine of the Ludwig Maximilian University of Munich
- 2012 Head of preclinical imaging at the Ludwig Maximilian University of Munich
- 2013 Head of the Department of nuclear medicine at Vienna General Hospital
- Deputy Chair of the Department of biomedical imaging and image-guided therapy at the Medical University of Vienna
- Department of nuclear medicine at the Theranosticum Vienna
Awards & Memberships
- Speaker of the International Atomic Energy Agency
- Official Member of the PRIMO MEDICO
Languages
English
German
Publications
Synthesis and preclinical evaluation of BOLD-100 radiolabeled with ruthenium-97 and ruthenium-103.
26 March, 2024
Phase II single-arm study of a combination of obinutuzumab and venetoclax in early relapsed or refractory diffuse large B-cell lymphoma—final results of the AGMT NHL15B study
March, 2024
A Fully Automated Synthesis of 14-(R,S)-[18F]fluoro-6-thia-heptadecanoic Acid ([18F]FTHA) on the Elixys Radiosynthesizer
February, 2024
Location
Währinger Gürtel, 18-20, 1090 Vienna, Austria
FAQ
Where does the doctor practice?
What is the specialization of Univ. Prof. Dr. med. Marcus Hacker?
The primary specialization of the doctor is nuclear medicine and prostate cancer.
What is the experience of the specialist?
Univ. Prof. Dr. med. Marcus Hacker has been practicing for more than 26 years.
Univ. Prof. Dr. med. Marcus Hacker
Get individual treatment plan and cost estimate. Non-binding 100% free assessment.
© Univ. Prof. Dr. med. Marcus Hacker
Similar Doctors
MINUTE Medical Vienna
prostate cancer theranostics, nuclear medicine and radiation protection
Dobling Private Hospital Vienna
theranostics, nuclear medicine, diagnostics, prostate and thyroid cancer
Dobling Private Hospital Vienna
nuclear medicine, radiopharmaceutical chemistry, radiopharmacy, imaging biomarkers
University Hospital Charite Berlin
radiology, nuclear medicine, medical physics
University Hospital Rechts der Isar Munich
nuclear medicine, molecular and radionuclide therapy